Hyperion Therapeutics Inc (NASDAQ:HPTX)

Add to Watch List

Set Alert

Friday’s trading has closed, but HPTX is being traded in the after-hours session. After-Hours quote »

21.15 Data as of 4:00pm ET	+0.62 / +3.02% Today’s Change	9.95 Today\|\|\|52-Week Range 26.50	+87.50% Year-to-Date

21.15

Data as of 4:00pm ET

+0.62 / +3.02%

Today’s Change

9.95

Today|||52-Week Range

26.50

+87.50%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$411.5M

Company Description

Hyperion Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The company is developing Ravicti to treat the most prevalent urea cycle disorders and hepatic encephalopathy. The urea cycle disorders and hepatic encephalopathy generally characterized by elevated levels of ammonia in the bloodstream. Its product candidate, Ravicti, is designed to lower ammonia in the blood. The company was founded on November 1, 2006 and is headquartered in South San Francisco, CA.

Contact Information

Hyperion Therapeutics, Inc.

601 Gateway Boulevard

South San Francisco California 94080

P:(650) 745-7802

Investor Relations:
(650) 745-7829

www.hyperiontx.com

Employees

Shareholders

Individual stakeholders	54.58%
Mutual fund holders	4.28%
Other institutional	38.80%

Top Executives

Donald J. Santel	President, Chief Executive Officer & Director
Jeffrey S. Farrow	Chief Financial Officer & Secretary
Dion F. Coakley, PhD	Global Vice President-Clinical Operations
Bruce F. Scharschmidt, MD	Chief Medical Officer & Senior Vice President
Christine A. Nash, MBA	Chief Commercial Officer & Senior Vice President

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.